Silicon Laboratories Inc. — Form 10-Q Summary
Period clarification: The filing covers the quarter ended September 29, 2012, not 2011 Q3 as specified in the request. Comparatives are the quarter ended October 1, 2011; nine-month results are also presented. Financial amounts below are in U.S. dollars.
Business context and reporting period
Silicon Laboratories designs analog-intensive, mixed-signal integrated circuits and operates as a fabless semiconductor company, relying on third parties for wafer fabrication, assembly and testing. Its products serve communications, consumer, industrial and automotive markets. Samsung was its only customer exceeding 10% of nine-month revenue; 89% of nine-month revenue came from outside the United States.
Financial performance
| Metric | Q3 2012 | Q3 2011 | Nine months 2012 | Nine months 2011 |
|---|---|---|---|---|
| Revenue | $149.5 million | $119.1 million | $410.8 million | $364.9 million |
| Gross margin | $86.5 million; 57.9% | $72.9 million; 61.2% | $244.4 million; 59.5% | $221.3 million; 60.6% |
| Operating income | $27.2 million; 18.2% of revenue | $13.9 million; 11.7% | $60.4 million; 14.7% | $34.9 million; 9.5% |
| Net income | $10.0 million | $11.3 million | $44.9 million | $22.7 million |
| Diluted EPS | $0.24 | $0.26 | $1.04 | $0.50 |
| Operating cash flow | Not separately stated | Not separately stated | $84.3 million | $65.6 million |
- Quarterly revenue rose 25.5%; management attributed growth primarily to market-share gains and Ember acquisition revenue. Unit volumes increased 20.2% and average selling prices increased 4.3% year over year.
- Nine-month revenue grew 12.6%; unit volumes rose 15.6%, while average selling prices declined 2.7%.
- Quarterly gross margin fell 3.3 percentage points, principally due to Ember-related charges. Operating income increased despite higher research and development spending.
- Quarterly net income declined despite higher operating income, chiefly reflecting income tax expense of $17.1 million versus $3.0 million a year earlier; the effective tax rate was 63.0% versus 20.9%. Nine-month effective tax rates were 27.6% and 38.0%, respectively.
- Nine-month investing cash outflow was $106.6 million, including $99.7 million of property and equipment purchases and $71.9 million for business acquisitions, partly offset by investment maturities and sales. Financing cash inflow was $52.8 million, including $98.3 million net debt proceeds and $51.0 million of share repurchases.
Balance sheet, debt and liquidity
- At September 29, 2012, cash and cash equivalents were $125.5 million, short-term investments $148.6 million and long-term investments $11.4 million. Cash, cash equivalents and short-term investments totaled $274.1 million; approximately $94.1 million was held by U.S. entities.
- Total assets were $855.0 million and stockholders’ equity $621.2 million. Current assets were $445.0 million versus current liabilities of $116.2 million.
- The company had $100 million outstanding under a five-year term loan, of which $5 million was current; it had not drawn on its $130 million revolving facility. The term loan’s LIBOR component was swapped to a fixed 0.764%; the combined rate including the applicable margin was 2.514% at quarter-end.
- The credit agreement includes a maximum leverage ratio of 2.5-to-1 and a minimum fixed-charge coverage ratio of 1.50-to-1. The company reported compliance with covenants at quarter-end and stated that available liquidity and credit should cover requirements for at least 12 months.
- Accounts receivable rose to $75.7 million from $55.4 million at year-end; DSO increased to 46 days from 39. Inventory rose to $42.5 million from $34.8 million; DOI was 61 days versus 63.
Material changes, outlook and notable items
- Ember acquisition: Acquired July 3, 2012, for approximately $79.0 million, including estimated contingent consideration of $4.0 million. The acquisition added low-power wireless IC and mesh-networking technology; acquired in-process R&D was valued at $14.8 million, and the allocation remains preliminary. Related products were not expected to contribute revenue before fiscal 2013.
- Headquarters purchase: Purchased Austin headquarters facilities on September 28 for $94.4 million. Purchase accounting produced an $8.5 million gain recorded in SG&A, materially reducing reported SG&A expense. The gain is unusual and not indicative of recurring operations.
- Former CEO separation: The separation agreement resulted in approximately $3.2 million of expense, recognized over the service period.
- Guidance: Management forecast Q4 fiscal 2012 revenue of $145–$150 million and diluted EPS of $0.38–$0.43. It expected R&D expense to increase in absolute dollars in Q4 and SG&A to remain stable excluding the headquarters gain. Expected fiscal 2012 capital expenditures were $10–$14 million, excluding the headquarters purchase.
- Contingencies and risk: Patent litigation with MaxLinear includes claims and counterclaims; the company said it could not predict the outcome or financial impact. It also disclosed illiquid auction-rate securities with $12.5 million par value, all subject to failed auctions and maturities from 2033 to 2046; management did not expect to need the funds before maturity and recorded no other-than-temporary impairment. Key broader risks include semiconductor cyclicality and price erosion, customer concentration, long design and qualification cycles, dependence on third-party manufacturing, international exposure, and acquisition integration.
Important facts for investors to verify
- Confirm the requested period: this filing is 2012 Q3, while “2011 Q3” appears only as a comparative period.
- Assess whether Q4 revenue and EPS guidance was achieved, and how much revenue and margin contribution Ember subsequently generated.
- Separate recurring operating performance from the $8.5 million headquarters gain and acquisition-related costs; evaluate the causes and sustainability of lower gross margin.
- Track the unusually high Q3 tax rate, its acquisition-related components, and developments in unrecognized tax benefits and the IRS examination.
- Monitor debt repayment, covenant headroom, share repurchases and liquidity, including the restricted accessibility and valuation assumptions for auction-rate securities.
- Follow the MaxLinear litigation and any material change in estimated exposure, and review customer, distributor and supply-chain concentration.